Table 1. Demographic data and length of follow-up for patients with optic neuritis.

Pt. No.	Gender	Antibody status	Age at presentation (years)	Initial presentation*	Follow-up (months)	Age at last OCT (years)
1	Male	MOG-IgG +	43	ON	29	45
2	Male	MOG-IgG +	39	ON	16	40
3	Female	MOG-IgG +	51	ON	15	51
4	Female	MOG-IgG +	29	TM + ON	19	29.5
5	Female	MOG-IgG +	31	ON	25	32
6	Female	MOG-IgG +	52	ON	16	52
1	Male	AQP4-IgG +	68	TM	65	73
2	Female	AQP4-IgG +	36	ON	178	51
3	Female	AQP4-IgG +	39	ON	131	50
4	Female	AQP4-IgG +	8	ON & ADEM	170	15
5	Female	AQP4-IgG +	36	TM	202	52
6	Female	AQP4-IgG +	44	ON	142	55
7	Female	AQP4-IgG +	32	ON	48	36
8	Male	AQP4-IgG +	56	ON	134	66
9	Female	AQP4-IgG + & dsDNA +	19	ON	84	26
10	Male	AQP4-IgG +	41	TM	110	39

* Inaugural event.

TM = transverse myelitis, ON = optic neuritis, ADEM = acute disseminated encephalomyelitis, dsDNA = double stranded DNA

Age at last OCT—OCT performed within a mean 3 months of the last ON event.